During the last session, Seres Therapeutics Inc (NASDAQ:MCRB)’s traded shares were 5.81 million, with the beta value of the company hitting 2.24. At the end of the trading day, the stock’s price was $0.73, reflecting an intraday loss of -4.01% or -$0.03. The 52-week high for the MCRB share is $6.73, that puts it down -821.92 from that peak though still a striking 26.03% gain since the share price plummeted to a 52-week low of $0.54. The company’s market capitalization is $110.16M, and the average trade volume was 4.04 million shares over the past three months.
Seres Therapeutics Inc (NASDAQ:MCRB) trade information
Seres Therapeutics Inc (MCRB) registered a -4.01% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.01% in intraday trading to $0.73, hitting a weekly high. The stock’s 5-day price performance is 16.29%, and it has moved by -7.35% in 30 days. Based on these gigs, the overall price performance for the year is -88.78%.
Seres Therapeutics Inc (MCRB) estimates and forecasts
Statistics show that Seres Therapeutics Inc has underperformed its competitors in share price, compared to the industry in which it operates. Seres Therapeutics Inc (MCRB) shares have gone down -52.32% during the last six months, with a year-to-date growth rate less than the industry average at -29.21% against 12.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.22%. While earnings are projected to return -20.06% in 2024.
MCRB Dividends
Seres Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
